Target Price | $295.80 |
Price | $272.33 |
Potential | 8.62% |
Number of Estimates | 22 |
22 Analysts have issued a price target Travelers 2026 . The average Travelers target price is $295.80. This is 8.62% higher than the current stock price. The highest price target is $336.00 23.38% , the lowest is $228.82 15.98% . | |
A rating was issued by 30 analysts: 12 Analysts recommend Travelers to buy, 16 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Travelers stock has an average upside potential 2026 of 8.62% . Most analysts recommend the Travelers stock at Hold. |
18 Analysts have issued a sales forecast Travelers 2025 . The average Travelers sales estimate is $45.6b . This is 4.68% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $47.8b 0.01% , the lowest is $43.9b 8.15% .
This results in the following potential growth metrics:
2024 | $46.4b | 12.23% |
---|---|---|
2025 | $45.6b | 1.76% |
2026 | $47.5b | 4.18% |
2027 | $49.5b | 4.11% |
2028 | $50.7b | 2.47% |
2029 | $52.3b | 3.09% |
2 Analysts have issued an Travelers EBITDA forecast 2025. The average Travelers EBITDA estimate is $7.4b . This is 50.03% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.7b 48.05% , the lowest is $7.2b 51.51% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $14.3b | 33.28% |
---|---|---|
2025 | $7.4b | 48.27% |
2026 | $8.7b | 18.30% |
2027 | $7.9b | 9.56% |
2024 | 30.74% | 18.75% |
---|---|---|
2025 | 16.19% | 47.33% |
2026 | 18.38% | 13.53% |
2027 | 15.97% | 13.11% |
27 Travelers Analysts have issued a net profit forecast 2025. The average Travelers net profit estimate is $5.0b . This is 3.29% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $5.6b 6.71% , the lowest is $4.3b 17.07% .
This results in the following potential growth metrics and future Net Margins:
2024 | $5.0b | 67.09% |
---|---|---|
2025 | $5.0b | 1.49% |
2026 | $5.8b | 15.31% |
2027 | $6.2b | 5.99% |
2028 | $4.8b | 21.96% |
2029 | $5.5b | 15.29% |
2024 | 10.69% | 48.88% |
---|---|---|
2025 | 11.04% | 3.31% |
2026 | 12.22% | 10.69% |
2027 | 12.44% | 1.80% |
2028 | 9.47% | 23.87% |
2029 | 10.59% | 11.83% |
27 Analysts have issued a Travelers forecast for earnings per share. The average Travelers EPS is $22.37 . This is 1.45% lower than earnings per share in the financial year 2024. The highest EPS forecast is $24.68 8.72% , the lowest is $19.18 15.51% .
This results in the following potential growth metrics and future valuations:
2024 | $21.47 | 67.87% |
---|---|---|
2025 | $22.37 | 4.19% |
2026 | $25.79 | 15.29% |
2027 | $27.33 | 5.97% |
2028 | $21.33 | 21.95% |
2029 | $24.59 | 15.28% |
Current | 12.00 | 19.15% |
---|---|---|
2025 | 12.18 | 1.53% |
2026 | 10.56 | 13.30% |
2027 | 9.96 | 5.68% |
2028 | 12.77 | 28.21% |
2029 | 11.07 | 13.31% |
Based on analysts' sales estimates for 2025, the Travelers stock is valued at an EV/Sales of 1.52 and an P/S ratio of 1.34 .
This results in the following potential growth metrics and future valuations:
Current | 1.45 | 4.32% |
---|---|---|
2025 | 1.52 | 4.86% |
2026 | 1.46 | 4.01% |
2027 | 1.40 | 3.95% |
2028 | 1.37 | 2.41% |
2029 | 1.33 | 3.00% |
Current | 1.28 | 5.70% |
---|---|---|
2025 | 1.34 | 4.91% |
2026 | 1.29 | 4.02% |
2027 | 1.24 | 3.94% |
2028 | 1.21 | 2.41% |
2029 | 1.17 | 3.00% |
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Neutral
➜
Neutral
|
Unchanged | Jul 21 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 18 2025 |
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Jul 18 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 10 2025 |
Barclays |
Overweight
➜
Equal-Weight
|
Downgrade | Jul 07 2025 |
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | May 28 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 19 2025 |
Analyst Rating | Date |
---|---|
Unchanged
UBS:
Neutral
➜
Neutral
|
Jul 21 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Jul 18 2025 |
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Jul 18 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Jul 10 2025 |
Downgrade
Barclays:
Overweight
➜
Equal-Weight
|
Jul 07 2025 |
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
May 28 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
May 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.